Updates

Regular updates related to sourcing and the management of health products are available on this page.

07 April 2026

Opportunity for Evaluation of Finished Pharmaceutical Products Lenacapavir for Pre-Exposure Prophylaxis
10 March 2026

Opportunity for Evaluation of Pharmaceutical Products – Antituberculosis Medicines
15 July 2025

Opportunity for Evaluation of Pharmaceutical Products – Antituberculosis Medicines
13 August 2024

TB Ag Skin test (Cy-Tb) for Mycobacterium tuberculosis infection diagnosis manufactured by Serum Institute of India Pvt. Ltd. (SIIPL) recently recommended for use by Expert Review Panel
15 July 2024

Opportunity for Evaluation of Pharmaceutical Products – Antituberculosis Medicines
24 April 2024

New Quality Assurance Policy on Vector Control Products and Related Equipment
16 April 2024

Post-market surveillance of insecticide-treated nets
12 February 2024

Opportunity for Evaluation of Pharmaceutical Products – Antituberculosis Medicines
24 January 2024

Revised Quality Assurance Policies for Pharmaceuticals and Medical Devices (including In Vitro Diagnostics) and Core Personal Protective Equipment
21 November 2023

Update to Evaluation of Diagnostic Products – African-Manufactured HIV Rapid Tests
22 May 2023

Opportunity for Evaluation of Diagnostic Products - Malaria Rapid Diagnostic Tests
19 October 2022

Opportunity for Evaluation of Diagnostic Products
18 July 2022

Placing Orders and Procuring Health Products for 2023
13 June 2022

Opportunity for Evaluation of Diagnostic Products – Syphilis Diagnosis
20 May 2022

New Isoniazid/rifapentine and rifapentine generic for tuberculosis (TB) prevention recently recommended for use by ERP
08 April 2022

Opportunity for Evaluation of Diagnostic Products
17 March 2022

Global Health Supply Chain Dialogue
10 March 2022

Misleading CE Mark Documentation Certification Issued by Real Companies
18 February 2022

Recalling US FDA Safety Communication on Pulse Oximeter Accuracy and Limitations
02 December 2021

The Supply Chain Roadmap